Bertrand Landel

Novel nanomagnetic beads for DNA/RNA and cell separation processes for life sciences, IVD and therapeutic uses. Recruited to lead fundraising and transition company from R&D to commercial stage.

• Secured €1.5M in seed funding from government, HNWIs, and family offices
• Built commercial partnerships in the US and EU, driving growth to €500K revenue (2025), €4.5M+ (2026)
• Optimized supplier relationships, reducing costs by 20%
• Established governance structures, including board and advisory appointments

Worked with portfolio companies on implementing commercial processes and supporting CEO on next round of fundraise, exploring sale of an asset.

• Developed financial planning for next round of fundraising
• Implemented B2B sales strategy, leading to two PoCs worth CHF 100K+
• Led restructuring of a portfolio asset (organ-on-chip technology), sourcing buyers and partners

Established and led Business Development function for an integrated IVD company offering SARS-CoV-2 PCR testing kits, lab and sampling services.

• Expanded pipeline across 10+ markets, securing high-volume COVID-19 screening contracts
• Scaled testing services from CHF 200K/month to CHF 10M+/month revenue operations at Zurich Airport
• Launched Southeast Asian office and partnerships in Asia, US, and Africa

Funded and founded a digital-health company to improve patient-practitioner engagement in consultations through tailored visualization of complete patient information and records.

• Sourcing and implementing two hospital-based pilot projects to validate product and customer needs
• Built a multidisciplinary team, driving product development and market validation.

Working as part of the global Public Affairs team to support local capability-building.

• Co-created strategic and tactical approaches with Market Access for government, payers across all Novartis divisions
• Oversaw public affairs strategy and market-shaping activities for Novartis in India, Turkey and Sub-Saharan Africa

Led strategic marketing function for active implantable medical devices including service development, pricing, segmentation, tendering and leading new market entry planning and execution.

• Implemented a €3M initiative to develop a new market segment, driving 15% YoY revenue growth.
• Achieved an 80% success rate in responding to 20+ public and private tenders across Middle East & Central and Eastern Europe.

Designed and implemented Public Affairs strategies to support commercial priorities of client companies.

• Opened Brussels office for London-based public affairs agency, built a team, lead client projects (500k€ in year 1).